DekaBank Deutsche Girozentrale
BNR

DekaBank Deutsche Girozentrale’s Burning Rock Biotech BNR Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-265
Closed -$428K – 1427
2021
Q3 		$428K Sell
265
-18
-6% -$4K ﹤0.01% 1086
2021
Q2 		$772K Buy
+283
New +$83.7K ﹤0.01% 971

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DekaBank Deutsche Girozentrale's BNR Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of Burning Rock Biotech (BNR) in Q4 2021, closing a stake of 265 shares — an estimated $428K sold.

DekaBank Deutsche Girozentrale first reported a position in BNR in Q2 2021 and held it in 2 quarters. The position peaked at $772K in Q2 2021. 62 funds tracked by Wall St. Rank hold BNR as of Q4 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Burning Rock Biotech position as of Q4 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 265 Burning Rock Biotech shares in Q4 2021, an estimated $428K.
  • DekaBank Deutsche Girozentrale first reported a position in Burning Rock Biotech in Q2 2021 and held it in 2 quarters.
  • DekaBank Deutsche Girozentrale's Burning Rock Biotech position peaked at $772K in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.